Product Information
GLYCOPYRROLATE 0.2 MG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.5143 per ML under NDC 00143968225. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Sep 21, 2011. Its Orange Book therapeutic-equivalence code is AP.
Strength
.2 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143968225
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA090963FDA Approved
9/21/2011
TE Code
AP
On Market Since
9/21/2011
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has been published 94 times since Dec 18, 2024, and over the history we have for it it has risen 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5143 per ML |
|---|---|
| All-time high | $1.5856 (Aug 13, 2025) |
| All-time low | $1.2855 (May 20, 2026) |
| 52-week high | $1.5143 |
| 52-week low | $1.2855 |
| Median price | $1.4806 |
| Average price | $1.4546 |
| Largest weekly change | -14.9% (Mar 18, 2026) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glycopyrrolate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 0.2 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 0.2 MG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $1.5143 per ML (NDC 00143968225), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 0.2 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has risen 8.3%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 0.2 MG/ML VIAL?
Since Dec 18, 2024, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has ranged from a low of $1.2855 (May 20, 2026) to a high of $1.5856 (Aug 13, 2025), with a median of $1.4806 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 0.2 MG/ML VIAL?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYCOPYRROLATE 0.2 MG/ML VIAL, is $1.5137 per ML — about 0% below GLYCOPYRROLATE 0.2 MG/ML VIAL.
Who manufactures GLYCOPYRROLATE 0.2 MG/ML VIAL?
GLYCOPYRROLATE 0.2 MG/ML VIAL (NDC 00143968225) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.